Dexcom


Dexcom Drops 9% As Revenue Beat Fails To Impress Investors

Shares in Dexcom (DXCM) dropped 9% on Tuesday after the medical device company pre-announced revenue of $500.9M.

DexCom: More Good News For Diabetes Patients And Shareholders

DexCom (NASDAQ:DXCM) stock is trading up on news that its medical app system, the DexCom Share system, to be used in conjunction with …

Dexcom’s Smart Glucose Monitoring System Receives FDA Approval

Dexcom’s (NASDAQ: DXCM) G4 Platinum Continuous Glucose Monitoring System received FDA approval yesterday on January 27th. Dexcom develops monitors that detect glucose levels to …

William Blair Assigns Outperform On Dexcom Shares

In a research report issued today, William Blair analyst Ben Andrew assigned an Outperform rating on Dexcom (NASDAQ:DXCM). No price target was provided.

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts